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INTRODUCTION
Benign biliary strictures (BBS) can be caused by post-
operative injury, anastomotic injury following orthotopic 
liver transplantation (OLT), chronic pancreatitis, primary 
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Endoscopic therapy by balloon dilation and placement of multiple large-bore plastic stents is the treatment of choice for 
benign biliary stricture. This approach is effective but it typically requires multiple endoscopic sessions given the short 
duration of stent patency. The endoscopic approach for treatment of bile leak involves the placement of a stent with or 
without biliary sphincterotomy. The self-expandable metal stent (SEMS) has traditionally been used for palliation of 
malignant biliary strictures given the long duration of stent patency owing to their larger stent diameter. Recently, SEMS 
has been used in a variety of benign biliary strictures and leaks, especially with the design of the covered self-expandable 
metal stent (CSEMS), which permits endoscopic-mediated stent removal. The use of CSEMS in benign biliary stricture could 
potentially result in a decrease in endoscopic sessions and it is technically easier when compared to placement of multiple 
plastic stents. However, complications such as cholecystitis due to blockage of cystic duct, stent migration, infection and 
pancreatitis have been reported. The potential subsegmental occlusion of contralateral intrahepatic ducts also limits the 
use of CSEMS in hilar stricture. Certain techniques and improvement of stent design may overcome these challenges in the 
future. Thus, CSEMS may be appropriate in only highly selected conditions, such as refractory benign biliary stricture, 
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used routinely. This review focuses on the use of fully covered self-expandable metal stent for benign biliary strictures and 
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sclerosing cholangitis, and other inflammatory conditions 
(1-10) (Fig. 1). Postoperative strictures including 
cholecystectomy, common bile duct exploration, and 
anastomotic stricture following OLT are the most frequent 
(11). The clinical presentation of BBS can be broad 
including subclinical, abnormal liver function tests, 
abnormal imaging as characterized by bile duct dilatation, 
and complete biliary obstruction manifesting as abdominal 
pain, jaundice, and cholangitis. Patients suffering from 
postoperative stricture may present within a few days after 
surgery or have a delayed presentation if the stricture is 
minor. BBS is usually diagnosed by cross-sectional imaging 
such as computed tomography (CT), magnetic resonance 
cholangiopancreatography and exclusion of malignant 
condition. Bile leaks generally occur after hepato-biliary 
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surgery with postcholecystectomy being the most common 
cause (12). Leakage of cystic duct and duct of Luschka is 
generally the cause of biliary leak after cholecystectomy. 
Endoscopic placement of biliary plastic stents has long 
been widely accepted as the treatment of choice for benign 
biliary stricture and leaks. Recent data, however, have 
shown that covered SEMS (CSEMS) may offer benefits and 
can be used for these conditions (6, 7, 13-16).
       
Factors Determining Success Rate of Endoscopic 
Treatment for BBS
Endoscopic therapy by placing multiple plastic stents with 
or without balloon dilation is very effective in postoperative 
strictures, including post OLT and cholecystectomy, while 
the treatment outcomes are less favorable in chronic 
pancreatitis. Among the strictures related to post OLT, 
anastomotic strictures (AS) have a better response when 
compared to nonanastomotic strictures caused by ischemic 
injury (17). Location of strictures is also important in 
predicting treatment success. There are two major systems 
used for assessment of biliary stricture: the Bismuth 
system, which is based on the location of stricture, and 
the Strasberg classification, which is based on location and 
biliary leak (18, 19). Distally located BBS (below hepatic 
hilum) have a superior success rate than proximal BBS 
(stricture involving hepatic hilum) after endoscopic therapy 
(20).
Endoscopic Therapy for Benign Biliary 
Strictures
Treatment options for BBS include surgery, percutaneous 
approach, and endoscopic therapy. The treatment goals 
should be to improve and maintain bile duct patency as 
well as preventing recurrent stricture by performing the 
least invasive procedure. Thus, the endoscopic approach has 
been accepted as the treatment of choice given its efficacy 
and less invasive nature, compared to surgery. Insertion 
of one or more plastic stents with or without dilation has 
been used as the standard treatment because of ease of 
removal and cost. To maximize the treatment outcomes, the 
treatment strategy involves placement of additional large-
bore plastic biliary stents (10 French) over time and the 
stents can be exchanged periodically (every 3-6 months) for 
at least 1 year (1). Practically, patients would undergo at 
least three endoscopic sessions within a year to complete 
the treatment protocol, which is the major disadvantage of 
this approach. In addition, suboptimal stricture resolution 
and the development of cholangitis due to stent occlusion 
are the important limitations of this approach. Thus, the 
use of SEMS, with its’ immediate radial expansion capability, 
has been proposed to lessen the number of endoscopic 
sessions. Also, the larger diameter of SEMS may potentially 
result in less stent occlusion and better stricture resolution. 
However, bare SEMS can create tissue hyperplasia and 
embedment, which would preclude stent removal, and so 
is not a recommended treatment for the benign condition. 
With the evolution of stent design, partially covered and 
fully covered SEMS have been developed. These stents allow 
temporary placement of SEMS and can therefore be used in 
BBS.
Partially Covered Self-Expandable Metal Stent 
(PCSEMS)
Studies have been conducted to assess stent patency, 
efficacy, removability, and complications of partially 
covered self-expandable metal stent (PCSEMS) in biliary 
strictures. A study of 79 patients who underwent placement 
of PCSEMS (Wallstent; Boston Scientific, Natick, MA, USA) 
for a variety of BBS including chronic pancreatitis, biliary 
stone disease, post-OLT, and post-surgery showed that 
overall success rate was about 90% after leaving the stents 
in place for 4 months. Stricture resolution rate was noted 
to be lowest in chronic pancreatitis. The authors were 
Fig. 1. Results of pancreatic stent treatment in benign 
biliary striture of different etiologies. Maximum result in post-
transplant stricture was found in anastomotic stricture whereas  
minimum result was found in non-anastomotic stricture. PSC = 
Primary sclerosing cholangitis, Max = Maximum percentage of 








MinKorean J Radiol 13(Suppl 1), Jan/Feb 2012 kjronline.org S69
Covered Metal Stent for Biliary Stricture and Leakage Treatment
able to removal all stents after biliary decompression, as 
confirmed by clinical and laboratory investigation. Median 
follow-up time after stent removal was 12 months. Stent 
migration occurred in 14% of cases, and tissue hyperplasia 
at the proximal uncovered portion of the stent resulting 
in stricture was also noted in some patients (13). The 
usefulness of PCSEMS in management of post-OLT related 
stricture after failure of conventional endoscopic therapy 
has also been demonstrated. Vandenbroucke et al. (21) 
placed Wallstents in patients with biliary stricture due to 
post-OLT who failed adequate balloon dilation. Twelve-, 
18-, and 24-month primary patency rate was 64%, 51%, 
and 26%, respectively. Two patients underwent re-
transplantation for diffuse ischemic cholangitis or chronic 
rejection. Tee et al. (22) reported two cases of AS refractory 
to the conventional endoscopic and/or surgical approach 
treated with insertion of a removable fully covered SEMS 
(Niti-S biliary stent; Taewoong Medical, Seoul, Korea). After 
successful deployment, the stent remained in situ for 42 
and 70 days, and no stent migration was observed. During 
an 18-month follow-up, liver function tests remained stable 
without further episode of jaundice and cholangitis, and 
no other procedures were required. Furthermore, in a recent 
prospective uncontrolled multicenter study of 22 patients 
(14) to evaluate the placement and removal of PCSEMS in 
the setting of AS post-liver transplantation, stents were 
placed for 2 months and all were removed except two due 
to distal migration. Stent insertion related complications 
included mild pancreatitis, transient abdominal pain, and 
cholangitis. The authors encountered minor complications 
associated with stent removal including self-contained 
hemorrhage and fever. A sustained stricture resolution rate 
of 52.6% was observed based on per protocol analysis. The 
stricture persisted at the end of treatment in three patients 
(13.6%); all were related to premature stent migration or 
dislocation. Recurrence of stricture after the initial success 
occurred in 47.4% of cases. The efficacy of PCSEMS in terms 
of stricture resolution for treatment of common bile duct 
stricture due to chronic pancreatitis is more favorable at a 
short-term follow-up when compared to a plastic stent (6, 
7). Despite an impressive initial response and a reasonably 
good stent patency at 12-20 months, the overall success 
rate of PCSEMS in treatment of chronic pancreatitis related 
bile duct stricture is disappointing (33%). Several studies 
have documented decreased stent patency over time as the 
patency rate dropped to 37.5% at 36 months (23, 24). 
Fully Covered Self-Expandable Metal Stent 
(FCSEMS)
To overcome the limitation of PCSEMS related to tissue 
hyperplasia, fully covered self-expandable metal stent 
(FCSEMS) was developed. The efficacy of this type of 
stent in the treatment of AS following OLT is promising. 
The stricture resolution rate ranges from 87.5-95.5% at a 
follow-up period of 6-12 months. Recurrence of the stricture 
occurs in a very small number of patients. Stent migration 
is observed in many patients but no major complications 
have been reported (5, 25). The treatment results of 
chronic pancreatitis related bile duct stricture with FCSEMS, 
however, are less favorable. 
In 2008, Cahen et al. (26) reported a small series of six 
patients who underwent placement of FCSEMS (Hanaro; 
Korea) for distal BBS from chronic pancreatitis. Stents 
could be removed in four patients and all achieved stricture 
resolution. One patient developed restenosis after 6 months. 
Two of six patients developed proximal stent migration 
resulting in unsuccessful stent removal. They subsequently 
underwent surgery to remove stents. A larger study by 
Mahajan and colleagues (6) analyzed the efficacy and 
complication rate of FCSEMS with and anchoring fin (Viabil; 
Conmed, USA) in 44 patients with BBS. In this study, nine 
patients had AS. The median time of SEMS placement was 3.3 
months. Resolution of biliary stricture was demonstrated in 
34 of 41 patients (83%), including all nine cases of AS after 
a median follow-up time of 3.8 months after stent removal. 
Chronic pancreatitis related stricture, however, had a lower 
resolution rate. The authors commented on the difficulty 
during stent removal due to the anchoring fin. In addition, 
bile duct injury after stent extraction was observed in 19 
patients by choledochoscopy. Subsequently, Sauer et al. (15) 
reported their 8-year experience of the temporary CSEMS in 
121 patients with BBS. This retrospective study compared 
the treatment results between FCSEMS and PCSEMS. FCSEMS 
were placed in 45% of the patients while PCSEMS were 
placed in 55%. The stents remained in place for a mean of 
165 ± 202 days. The mean follow-up after stent removal was 
735 ± 577 days. Overall stricture resolution was achieved in 
63%; only 50% in chronic pancreatitis compared with 71% 
for other etiologies. A 20% complication rate was reported 
due to stent placement and 12% had complications during 
stent removal. Stent migration occurred in 16% of the 
patients. To facilitate stent removal, Wallflex stents (Boston 
Scientific) with flared ends and distal loop for stent Korean J Radiol 13(Suppl 1), Jan/Feb 2012 kjronline.org S70
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retrieval were introduced. 
Brijbassie et al. (16) conducted a multicenter 
retrospective study of 59 patients with chronic pancreatitis 
using Wallflex stents. Stents were removed and stricture 
resolution rate was 88.9% demonstrated by imaging, 
91.4% documented by laboratory findings, 78.5% based 
on symptoms, and 85.7% by direct visualization by 
choledochoscopy. Minor complications included abdominal 
pain, pancreatitis, and stent migration.
Even though the data on CSEMS in the treatment of BBS 
is encouraging, the balance between its benefit of stricture 
resolution rate and risks including migration, infection, 
pancreatitis, and inability to remove stents should be 
strongly considered before replacing plastic stents with 
FCSEMS for treatment of BBS in routine practice. In a 
systematic review of plastic stents and metal stents for 
extrahepatic biliary strictures, the overall clinical success 
rate was 60% for single plastic stent, 94% for multiple 
plastic stents, and 79% for uncovered SEMS (27). Currently, 
comparative data on the efficacy of multiple plastic stents 
and covered SEMS in benign biliary stricture is lacking and 
therefore prospective studies are required.
Evolution of FCSEMS Design
The weaknesses of FCSEMS are stent migration, duodenal 
reflux, tissue hyperplasia, and ease of removal. These issues 
should be addressed in the development of stent in order 
to strengthen stent quality. To minimize stent migration, 
the concept of flared ends and anchoring flap has been 
introduced. Tringali et al. (28) performed a study using a 
nitinol covering (Niti-S; Taewoong Medical) with unflared 
and flared ends in 17 patients with common bile duct 
strictures secondary to chronic pancreatitis. After 6 months 
of placement and 3 years of follow-up, the flared ends had 
superior efficacy (87% vs. 43%) and less migration rate (57% 
vs. 50%). Park et al. (7) compared two types of FCSEMS; 
one with four anchoring flaps (AF) at the proximal end and 
flared distal end, and the other had flared end (FE) at both 
proximal and distal parts without AF, in 43 patients with 
BBS. After a median stent placement period of 6 months, 
no patients in the AF group and 33% of patients in the 
FE group had stent migration (p = 0.004). The removal 
rate of the FCSEMSs was 100% in both groups without 
difficulty. Immediate improvement of biliary stricture was 
91% in the AF group and 88% in the FE group. During the 
follow-up period (median 4 months) after stent removal 
or migration, 16% had recurrence of the initial biliary 
stricture. Importantly, none of post surgical BBSs developed 
recurrence. The authors concluded that the AF design may 
be superior to the FE, with regard to the antimigration 
effect for benign biliary stricture and BBS from surgery had 
an excellent response.
Recently, a retrievable polytetrafluoroethylene (PTFE)-
FCSEMS with a ball type wire mesh at the distal end (Bumpy 
stent, diameter 10 mm; Taewoong Medical), was designed 
for anti-migration and anti-reflux (29). The design to 
improve the ease of stent removal has also been developed 
by adding proximal retrievable loop allowing the stent to be 
pulled inside-out more easily during removal. Researchers 
from the Netherlands under the leadership of J.W. Poley are 
currently conducting a prospective study assessing a new 
type of fully-covered, self-expandable metal stent with a 
proximal retrieval lasso for the treatment of benign biliary 
strictures. With a better understanding of stent physics, 
research is actively being conducted to achieve an optimal 
quality of FCSEMS with the goal to improve treatment 
outcomes of patients suffering from BBS.
Complications of FCSEMS Insertion 
Stent migration has been a major obstacle of FCSEMS. 
It is hoped that the newer stent designs will decrease this 
problem. Acute pancreatitis is another well documented 
complication. Although most cases of pancreatitis are mild, 
SEMS results in higher rate of acute pancreatitis when 
compared to plastic stents (7.3% vs. 1.3%). The proposed 
mechanism for this observation is that the CSEMS may have 
higher chance of causing pancreatic orifice occlusion given 
its larger diameter (30). Independent predictors of post 
ERCP pancreatitis (PEP) are young age, previous history of 
PEP, and pancreatic duct injection. Acute cholecystitis and 
cholangitis can occur as both early and late complications 
if the cystic duct insertion is occluded (31). The reported 
rate of cholecystitis after PCMS placement ranges between 
2.9% and 12% (32, 33).
Measures to Minimize Complications from 
FCSEMS Insertion
To prevent stent migration, insertion of a double pigtail 
stent as stent-in stent or through the SEMS mesh has been 
proposed (8, 34) (Fig. 2). However, there has not been a 
randomized control study to compare the results of this Korean J Radiol 13(Suppl 1), Jan/Feb 2012 kjronline.org S71
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strategy. One other concern raised by experts is placing 
FCSEMS in the hilar stricture due to the theoretical risk 
of creating sub-segmental occlusion of the contralateral 
intrahepatic ducts by the stent membrane. This issue may 
be addressed by placing a plastic stent in the contralateral 
intrahepatic ducts to facilitate bile flow before placing the 
fully covered SEMS. The authors have successfully placed 
a 6 x 120 mm FCSEMS into the left intrahepatic duct along 
with a 7 French plastic stent to the right system in a case 
of benign biliary stricture (Fig. 3). Poley et al. (35) also 
reported a series of two patients who underwent placement 
of an intrahepatically deployed FCSEMS in conjunction with 
a contralateral 10 French plastic stent for 4-5 months. Both 
strictures resolved, and there were no signs of a recurrent 
stricture after a 9-month follow-up. No complications were 
reported. 
Issues to Consider Prior to Using FCSEMS in 
Routine Practice
Besides the previously mentioned complications 
including an increased risk of stent migration, pancreatitis, 
cholecystitis, and potential difficulty in stent removal, cost 
of FCSEMS could be a major limiting factor in a routine 
use of this stent. The cost effectiveness ratio (ICER) is 
the best way to determine the selection. It requires a 
calculation of stent cost, number of ERCP sessions, and the 
cost for additional ERCPs. The selected intervention can be 
determined as cost effective if its ICER is less expensive 
than having additional procedure(s). Currently, this issue 
has not been assessed. However, it has been estimated that 
SEMS placement may be cost-effective if the total cost of 
additional ERCPs for plastic stent upsizing is more expensive 
than US$2100. This estimate was adopted of the results 
from previous study on SEMS treatment for recurrent stent 
occlusion in patients with malignant biliary stricture (36). 
Metal Stents in Bile Leaks
Most bile leaks can be managed successfully with plastic 
stents with or without biliary sphinterotomy. Therefore, 
the role of SEMS in this condition is limited. CSEMS may be 
beneficial in a select group of patients who fail conventional 
endoscopic therapy. In one study, PCSEMS (Wallstent) were 
placed in 16 patients who failed plastic stent placement 
and were left in place for a median duration of 3 months. 
Fig. 2. Method to prevent fully covered stent migration. 
Double pigtail plastic stent was inserted as stent-in-stent to lock  
movement of fully covered metal stent.
Fig. 3. Method to provide subsegmental drainage when fully 
covered stent was inserted in benign biliary stricture near 
hepatic hilum. Plastic stent was inserted into contralateral 
intrahatic duct after small (6 x 120 mm) fully covered metal stent 
was inserted into left intrahepatic duct.Korean J Radiol 13(Suppl 1), Jan/Feb 2012 kjronline.org S72
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All except one patient had complete resolution of leak and 
stent migration was responsible for treatment failure (2). 
Wang et al. (37) reported the use of the Viabil stent in 13 
patients with complexed bile leaks. Complete resolution 
was observed in all with complications included a stricture 
below the confluence in two patients. Hwang et al. (29) 
also reported a successful treatment in patients who had 
refractory bile leaks with a newly designed retrievable PTFE-
FCSEMS with a ball type wire mesh at the distal end. The 
data on usefulness of FCSEMS in treatment of biliary leaks is 
currently limited.
In conclusion, FCSEMS may be a reasonably good 
alternative treatment option for difficult BBS and bile 
leaks. The current data, however, is lacking to demonstrate 
the superiority of FCSEMS over plastic stent placement. 
Randomized controlled studies assessing stent efficacy, 
complications, and cost-effectiveness are needed before a 
routine use of this modality in BBS and bile leaks can be 
recommended. The authors propose that FCSEMS should be 
considered in selected circumstances including refractory 
benign biliary stricture and difficult to treat bile duct 
stricture from chronic pancreatitis. 
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